Good Predictive Value of Combined Cytogenetic and Molecular Follow Up in Chronic Myelogenous Leukemia After Non T-cell Depleted Allogeneic Bone Marrow Transplantation: A Report on 38 Consecutive Cases

References

• Kurzrock R., Gutterman J., Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N. Engl J. Med. 1988; 319: 990–998
   PubMed Web of Science ®Google Scholar
• Hughes T.P., Morgan G.J., Martiat P., Goldman J.M. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse. Blood 1991; 77: 874–878
   PubMed Web of Science ®Google Scholar
• Miyamura K., Tahara T., Tanimoto M., Morishita Y., Kawashima K., Morishima Y., Saito H., Tsuzuki S., Takeyama K., Kodera Y., Matsuyama K., Hirabayashi N., Yamada H., Naito K., Imai K., Sakamaki H., Asai O., Mizutani S. Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients. Blood 1993; 81: 1089–1093
   PubMed Web of Science ®Google Scholar
• Guerrasio A., Martinelli G., Saglio G., Rosso C., Zaccaria A., Rosti G., Testoni N., Ambrosetti A., Izzi T., Sessarego M., Frassoni F., Gasparini P., Chiamenti A., Di Bartolomeo P., Pignatti P.F. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of poly-merase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants. Leukemia 1992; 6: 507–512
   PubMed Web of Science ®Google Scholar
• Cross T.P., Hughes N.C.P., Feng L., O'Shea P., Bungey J., Marks D.I., Ferrdnt A., Martiat P., Goldman J.M. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlation with acute graft-versus-host disease and relapse. B. J. Haematol. 1993; 84: 67–74
   PubMed Web of Science ®Google Scholar
• Delfau M.H., Kerckaert Collyn J.P., d'Hooghe M., Fenaux P., Lai J.L., Jouet J.P., Grandchamp B. Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. Leukemia 1990; 4: 1–5
   PubMed Web of Science ®Google Scholar
• Roth M.S., Antin J.H., Ash R., Terry V.H., Gotlieb M., Silver S.M., Ginsburg D. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 1992; 79: 276–282
   PubMed Web of Science ®Google Scholar
• Gaiger A., Lion T., Kalhs P., Mitterbauer G., Henn T., Haas O., Fodinger M., Kier P., Forstinger C., Quehenberger P., Hinterberger W., Jager U., Linkesch W., Mannhalter C., Lechner K. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT). Leukemia 1993; 7: 1766–1772
   PubMed Web of Science ®Google Scholar
• Kantarjian H.M., Deisseroth A., Kurzrock R., Estrov Z., Talpaz M. Chronic myelogenous leukemia: a concice update. Blood 1993; 82: 691–703
   PubMed Web of Science ®Google Scholar
• Preudhomme C., Fenaux P., Lai J.L., Lepelley R., Sartiaux C., Collyn-d'Hooghe M., Zandecki M., Cosson A., Jouet J.P., Kerckaert J.P. Philadelphia negative, bcr-abl positive adult acute lymphoblastic leukemia (ALL) in 2 of 39 patients with combined cytogenetic and molecular analysis. Leukemia 1993; 7: 1054–1057
   PubMed Web of Science ®Google Scholar
• Millot F., Facon T., Kerckaert J.P., Fenaux P., Lai J.L., Parent M., Bauters F., Jouet I.P. Unusual recurrence of chronic myelogenous leukemia following bone marrow transplantation. Bone Marrow Transplantation 1991; 7: 393
   PubMed Web of Science ®Google Scholar
• Opalka B., Wandl U.B., Becher R., Klobe O., Nagel-Hiemke M., Moritz T., Beer U., Seeber S., Niederle N. Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant Interferon α-2b alone or in combination with Interferon γ. Blood 1991; 78: 2188–2193
   PubMed Web of Science ®Google Scholar
• Gribben J.G., Neuberg D., Barber M., Moore J., Pesek K.W., Freedman A.S., Nadler L.M. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood in significantly less predictive for relapse than detection in bone marrow. Blood 1994; 83: 3800–3807
   PubMed Web of Science ®Google Scholar
• Yokota C., Hanaen-Hagge T.E., Ludwig W.D., Reiter A., Raghavachar A., Kleihauer E., Bartram C.R. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 1991; 77: 331–339
   PubMed Web of Science ®Google Scholar
• Lin F., Goldman J.M., Cross N.C.P. A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukemia. B. J. Haematol. 1994; 86: 683–485
   PubMed Web of Science ®Google Scholar
• van Rhee F., Lin F., Cullis J.O., Spencer A., Cross N.C.P., Chase A., Garicochea B., Bungey J., Barrett J., Goldman J.M. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 1994; 83: 3377–3383
   PubMed Web of Science ®Google Scholar
• Cross N.C.P., Feng L., Chase A., Bungey J., Hughes T.P., Goldman J.M. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82: 1929–1936
   PubMed Web of Science ®Google Scholar